Chinese Journal of Dermatology ›› 2022, Vol. 55 ›› Issue (2): 153-156.doi: 10.35541/cjd.20200823
• Research Reports • Previous Articles Next Articles
Bao Shijie, Cheng Yang, Yan Ying, Fan Fang, Gao Tingting, Feng Xiaolan, Zheng Liang, Lei Wei, Huang Qinsi, Zhang Weiming, Zhou Xiaoyong
Received:
2020-08-17
Revised:
2021-07-25
Online:
2022-02-15
Published:
2022-01-27
Contact:
Zhou Xiaoyong
E-mail:13018097526@126.com
Bao Shijie, Cheng Yang, Yan Ying, Fan Fang, Gao Tingting, Feng Xiaolan, Zheng Liang, Lei Wei, Huang Qinsi, Zhang Weiming, Zhou Xiaoyong. A comparative study of human immunoglobulin versus recombinant human tumor necrosis factor-α receptor Ⅱ:IgG Fc fusion protein in the treatment of toxic epidermal necrolysis[J]. Chinese Journal of Dermatology, 2022, 55(2): 153-156.doi:10.35541/cjd.20200823
[1] | 杨永生, 徐金华, 李锋, 等. 静脉注射丙种球蛋白和糖皮质激素治疗重症大疱性药疹65例[J]. 中华皮肤科杂志, 2009,42(5):330⁃332. doi: 10.3760/cma.j.issn.0412⁃4030.2009.05.012. |
[2] | 孙杰, 刘晋, 龚晴丽, 等. 糖皮质激素和免疫球蛋白治疗中毒性表皮坏死松解症疗效分析[J]. 中华皮肤科杂志, 2015,48(9):633⁃636. doi: 10.3760/cma.j.issn.0412⁃4030.2015.09.010. |
[3] | 陈蕾, 李定, 马萍萍, 等. 重组人Ⅱ型肿瘤坏死因子受体-抗体融合蛋白联合糖皮质激素治疗中毒性表皮坏死松解症一例[J]. 中华皮肤科杂志, 2021,54(4):356⁃357. doi: 10.35541/cjd.20190896. |
[4] | Bastuji⁃Garin S, Fouchard N, Bertocchi M, et al. SCORTEN: a severity⁃of⁃illness score for toxic epidermal necrolysis[J]. J Invest Dermatol, 2000,115(2):149⁃153. doi: 10.1046/j.1523⁃1747.2000.00061.x. |
[5] | Zimmermann S, Sekula P, Venhoff M, et al. Systemic immunomodulating therapies for stevens⁃johnson syndrome and toxic epidermal necrolysis: a systematic review and meta⁃analysis[J]. JAMA Dermatol, 2017,153(6):514⁃522. doi: 10.1001/jamadermatol.2016.5668. |
[6] | Ye LP, Zhang C, Zhu QX. The effect of intravenous immunoglobulin combined with corticosteroid on the progression of Stevens⁃Johnson syndrome and toxic epidermal necrolysis: a meta⁃analysis[J]. PLoS One, 2016,11(11):e0167120. doi: 10.1371/journal.pone.0167120. |
[7] | Sekula P, Dunant A, Mockenhaupt M, et al. Comprehensive survival analysis of a cohort of patients with Stevens⁃Johnson syndrome and toxic epidermal necrolysis[J]. J Invest Dermatol, 2013,133(5):1197⁃1204. doi: 10.1038/jid.2012.510. |
[8] | Soares MO, Welton NJ, Harrison DA, et al. Intravenous immunoglobulin for severe sepsis and septic shock: clinical effectiveness, cost⁃effectiveness and value of a further randomised controlled trial[J]. Crit Care, 2014,18(6):649. doi: 10.1186/s13054⁃014⁃0649⁃z. |
[9] | Creamer D, Walsh SA, Dziewulski P, et al. UK guidelines for the management of Stevens⁃Johnson syndrome/toxic epidermal necrolysis in adults 2016[J]. J Plast Reconstr Aesthet Surg, 2016,69(6):e119⁃119e153. doi: 10.1016/j.bjps.2016.01.034. |
[10] | Romero⁃Tapia SJ, Cámara⁃Combaluzier HH, Baeza⁃Bacab MA, et al. Use of intravenous immunoglobulin for Stevens⁃Johnson syndrome and toxic epidermal necrolysis in children: report of two cases secondary to anticonvulsants[J]. Allergol Immunopathol (Madr), 2015,43(2):227⁃229. doi: 10.1016/j.aller.2013.12.008. |
[11] | Serati Shirazi Z, Inaloo S. Intravenous immunoglobulin in the treatment of lamotrigine⁃ induced toxic epidermal necrolysis[J]. Iran J Allergy Asthma Immunol, 2008,7(4):239⁃241. |
[12] | Chung WH, Hung SI, Yang JY, et al. Granulysin is a key mediator for disseminated keratinocyte death in Stevens⁃Johnson syndrome and toxic epidermal necrolysis[J]. Nat Med, 2008,14(12):1343⁃1350. doi: 10.1038/nm.1884. |
[13] | Kida Y, Kuwano K, Zhang Y, et al. Acholeplasma laidlawii up⁃regulates granulysin gene expression via transcription factor activator protein⁃1 in a human monocytic cell line, THP⁃1[J]. Immunology, 2001,104(3):324⁃332. doi: 10.1046/j.1365⁃2567. 2001.01310.x. |
[14] | Wang CW, Yang LY, Chen CB, et al. Randomized, controlled trial of TNF⁃α antagonist in CTL⁃mediated severe cutaneous adverse reactions[J]. J Clin Invest, 2018,128(3):985⁃996. doi: 10.1172/JCI93349. |
[15] | Paradisi A, Abeni D, Bergamo F, et al. Etanercept therapy for toxic epidermal necrolysis[J]. J Am Acad Dermatol, 2014,71(2):278⁃283. doi: 10.1016/j.jaad.2014.04.044. |
[16] | So N, Leavitt E, Aleshin M, et al. The use of etanercept for treatment of toxic epidermal necrolysis when toxic shock syndrome is in the differential[J]. Dermatol Ther, 2018,31(5):e12684. doi: 10.1111/dth.12684. |
[17] | 陆晓君, 经晶, 施辛, 等. 重组人Ⅱ型肿瘤坏死因子受体⁃抗体融合蛋白治疗中毒性表皮坏死松解症的临床疗效观察[J]. 中华皮肤科杂志, 2020,53(6):428⁃434. doi: 10.35541/cjd. 20200068. |
[18] | Famularo G, Di Dona B, Canzona F, et al. Etanercept for toxic epidermal necrolysis[J]. Ann Pharmacother, 2007,41(6):1083⁃1084. doi: 10.1345/aph.1K001. |
[19] | Wang F, Gao X, Chen X, et al. Successful treatment of interstitial lung disease related to Stevens⁃Johnson syndrome/toxic epidermal necrolysis overlap with etanercept: a case report and published work review[J]. J Dermatol, 2019,46(11):1035⁃1038. doi: 10.1111/1346⁃8138.15058. |
[20] | Bolitho P, Voskoboinik I, Trapani JA, et al. Apoptosis induced by the lymphocyte effector molecule perforin[J]. Curr Opin Immunol, 2007,19(3):339⁃347. doi: 10.1016/j.coi.2007.04.007. |
[21] | Trépanier P, Bazin R. Intravenous immunoglobulin (IVIg) inhibits CD8 cytotoxic T⁃cell activation[J]. Blood, 2012,120(13):2769⁃2770. doi: 10.1182/blood⁃2012⁃07⁃445007. |
[22] | Trépanier P, Chabot D, Bazin R. Intravenous immunoglobulin modulates the expansion and cytotoxicity of CD8+ T cells[J]. Immunology, 2014,141(2):233⁃241. doi: 10.1111/imm.12189. |
[23] | Jacobi C, Claus M, Wildemann B, et al. Exposure of NK cells to intravenous immunoglobulin induces IFN gamma release and degranulation but inhibits their cytotoxic activity[J]. Clin Immunol, 2009,133(3):393⁃401. doi: 10.1016/j.clim.2009.09.006. |
[1] | Zhang Ning, Li Shu, Li Jing . Efficacy of immune checkpoint inhibitors and targeted therapy in adjuvant treatment of resectable melanoma: a network meta-analysis [J]. Chinese Journal of Dermatology, 2022, 0(4): 20200767-e20200767. |
[2] | Wang Xiaowen, Li Ruoyu. Superficial fungal infections in psoriasis patients treated with IL-17 related biological agents and their management [J]. Chinese Journal of Dermatology, 2022, 55(3): 272-275. |
[3] | Liu Yuzhen, Zeng Rong, Zheng Nana, Duan Zhimin, Xu Haoxiang, Wu Qiuju, Lin Tong, Li Min. Effect of different incubation time of aminolevulinic acid on photodynamic inhibition of Propionibacterium acnes biofilms [J]. Chinese Journal of Dermatology, 2022, 55(3): 208-212. |
[4] | Writing committee expert group on “diagnosis and treatment of pustular psoriasis: a Chinese expert consensus statement”. Diagnosis and treatment of pustular psoriasis: a Chinese expert consensus statement (2022) [J]. Chinese Journal of Dermatology, 2022, 55(3): 187-195. |
[5] | Zhang Tingting, Zhu Fengyi, Yang Mei, Zhang Ping, Xia Ping, Zhou Xiaoyong. Clinical efficacy and safety of secukinumab in the treatment of 7 cases of erythrodermic psoriasis [J]. Chinese Journal of Dermatology, 2022, 0(2): 20210644-e20210644. |
[6] | Wen Guangdong, Mao Dandan, Zhang Yuanyuan, Dou Yuanqing, Zhao Pei, Wu Chenyu, Zhang Jianzhong. A case of generalized lichen amyloidosis treated with dupilumab: the first case reported in China [J]. Chinese Journal of Dermatology, 2022, 0(2): 20210694-e20210694. |
[7] | Li Sai, Xue Huazhong, Zhang Shuwen, Jiang Juan, Qi Shuzhen, Zhao Yuanyuan, Zhang Jinping, Sha Zhong, Le Wenjing, Wang Biwei, Zhao Shixuan, Zhu Xiaofeng, Su Xiaohong. Doxycycline-moxifloxacin sequential therapy for Mycoplasma genitalium urethritis/cervicitis: a clinical observation [J]. Chinese Journal of Dermatology, 2022, 0(2): 20210631-e20210631. |
[8] | Jiao Xiaoyan, Yin Guangwen, Yin Yakun, Li Dongqin. Clinical analysis of 25 cases of herpes zoster during pregnancy or the perinatal period [J]. Chinese Journal of Dermatology, 2022, 0(2): 20210384-e20210384. |
[9] | Ou Min, Yan Yunling, Zheng Baoqing, Wang Xiaohua. Correlations between psoriasis and obesity [J]. Chinese Journal of Dermatology, 2022, 55(2): 181-184. |
[10] | Guo Jing, Yang Jingyu, Ding Li, Liu Mingming, Hou Jingmei, Pu Xiaoxia, Sun Jiayu, Li Xianghua. Efficacy of long-pulsed 1 064-nm Nd:YAG laser combined with a topical emulsion containing Camellia reticulata and Radix Notoginseng in the treatment of melasma [J]. Chinese Journal of Dermatology, 2022, 55(1): 61-64. |
[11] | Chinese Society of Dermatology, China Dermatologist Association. Consensus on the diagnosis and treatment of autoimmune subepidermal bullous diseases (2022) [J]. Chinese Journal of Dermatology, 2022, 55(1): 1-11. |
[12] | Luan Chao, Hu Yu, Chen Kun, Zhang Jiaan, Gu Heng, Zhang Ronglin, Zhang Xiaohua, Tian Panpan, Zhu Yan, Zhuang Chen, Huang Dan, Ju Mei. Efficacy and safety of 308-nm SQ light-emitting diode light and 308-nm excimer light in the treatment of facial vitiligo: a retrospective study [J]. Chinese Journal of Dermatology, 2022, 55(1): 16-19. |
[13] | Lu Jiawei, Lu Yan. Paradoxical psoriasis induced by tumor necrosis factor-α inhibitors and other biological agents [J]. Chinese Journal of Dermatology, 2022, 0(1): 20210420-e20210420. |
[14] | Gao Rong, Zhang Lan, Li Zhengxiao. Biological agents in the treatment of moderate to severe plaque psoriasis and psoriatic arthritis [J]. Chinese Journal of Dermatology, 2022, 55(1): 72-75. |
[15] | Cao Meng, Hong Anlan, Wang Yan, Fang Fang. Clinical progress in pediatric melanoma [J]. Chinese Journal of Dermatology, 2022, 0(1): 20210158-e20210158. |
|